Novavax (NVAX) Shares Issued (2016 - 2024)
Historic Shares Issued for Novavax (NVAX) over the last 16 years, with Q2 2024 value amounting to $256.4 million.
- Novavax's Shares Issued rose 31365.79% to $256.4 million in Q2 2024 from the same period last year, while for Mar 2025 it was $256.4 million, marking a year-over-year increase of 4899.24%. This contributed to the annual value of $263.3 million for FY2024, which is 2691.82% down from last year.
- Novavax's Shares Issued amounted to $256.4 million in Q2 2024, which was up 31365.79% from $6.9 million recorded in Q1 2024.
- Novavax's 5-year Shares Issued high stood at $564.9 million for Q1 2021, and its period low was $1.5 million during Q2 2020.
- In the last 5 years, Novavax's Shares Issued had a median value of $179.4 million in 2022 and averaged $209.5 million.
- In the last 5 years, Novavax's Shares Issued skyrocketed by 4990000.0% in 2020 and then crashed by 6824.25% in 2022.
- Novavax's Shares Issued (Quarter) stood at $428.6 million in 2020, then skyrocketed by 31.81% to $564.9 million in 2021, then tumbled by 87.63% to $69.8 million in 2022, then skyrocketed by 47.82% to $103.2 million in 2023, then soared by 148.34% to $256.4 million in 2024.
- Its Shares Issued stands at $256.4 million for Q2 2024, versus $6.9 million for Q1 2024 and $103.2 million for Q4 2023.